Marshall Goldsmith

FEBRUARY 8, 2018

Thinkers50 – World’s Most Influential Management Thinkers. Called ‘The Academy Awards of Leadership’ by the Economist, Thinkers50 is the world’s most reliable resource for identifying, ranking and sharing the leading management ideas of our age. World authority on project management. Co-author: Predictable Magic.

Executive Coaching 70

Executive Coaching CEO Magazine Banking 70

Harvard Business Review

JUNE 9, 2017

During our careers, we have worked in industry, academia, clinical medicine, and government and have managed successful academia-industry collaborations. These scenarios are seldom contemplated in institutional management of conflicts of interest. Our experiences in both sectors have led us to this conclusion. Practicing physicians.

Conflict of Interest 9

Conflict of Interest Pharmaceuticals Policies Industry 9

Harvard Business Review

JUNE 8, 2015

Pharmaceutical companies, buffeted by regulatory changes, new drug technologies that alter entry barriers and competition, price pressures, and an estimated 300,000 job cuts since 2000, seem to fit the popular narrative of large organizations unable to deal with disruptive forces. It’s not just products. Experimentation is vital.

Health Care 8

Health Care Venture Capitalist Strategic Fit Pharmaceuticals 8

Harvard Business Review

MARCH 24, 2011

What makes the matter fascinating to industry watchers, approximately their equivalent of the Charlie Sheen supernova, is that Gupta served three terms as managing director of McKinsey & Co., In his tenure as McKinsey's worldwide managing director, Gupta displayed macher-like ambition not just for himself but even more so for his firm.

McKinsey 14

McKinsey Consultative Waterman Intellectual Capital 14

Harvard Business Review

JANUARY 10, 2013

initiative — prohibitions against off-label marketing under the False Claims Act — swept through the pharmaceutical industry. The most notable was Fannie Mae's $10.8 billion restatement. In another instance, a new enforcement. The largest payments were from Pfizer ($2.3 billion) and GlaxoSmithKline ($3 billion).

Finance 8

Finance Banking Press Release Pharmaceuticals 8

Harvard Business Review

SEPTEMBER 19, 2016

You have to approach these problems as a manager and do the best analysis you can, including hard-headed financial analysis. Imagine, for example, that you’re a pharmaceutical CEO deciding whether to recall a new drug. But perhaps managers have no choice. How should you make this decision?

ROI 8

ROI Long-term Conflict of Interest Pharmaceuticals 8